Should Envista Holdings' (NVST) Mixed Q3 Results and Share Buybacks Prompt Investor Re-evaluation?

Simply Wall St.11-12

In late October 2025, Envista Holdings reported third quarter results, showing year-over-year sales growth to US$669.9 million but a swing to a net loss of US$30.3 million, and updated its fiscal 2025...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2582394828?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2025-11-12 02:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582394828","market":"nz","top_or_hot":-1,"title":"Should Envista Holdings' (NVST) Mixed Q3 Results and Share Buybacks Prompt Investor Re-evaluation?","media":"Simply Wall St.","content":"<div>\n<p>In late October 2025, Envista Holdings reported third quarter results, showing year-over-year sales growth to US$669.9 million but a swing to a net loss of US$30.3 million, and updated its fiscal 2025...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-nvst/envista-holdings/news/should-envista-holdings-nvst-mixed-q3-results-and-share-buyb\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Should Envista Holdings' (NVST) Mixed Q3 Results and Share Buybacks Prompt Investor Re-evaluation?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShould Envista Holdings' (NVST) Mixed Q3 Results and Share Buybacks Prompt Investor Re-evaluation?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-12 02:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-nvst/envista-holdings/news/should-envista-holdings-nvst-mixed-q3-results-and-share-buyb><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In late October 2025, Envista Holdings reported third quarter results, showing year-over-year sales growth to US$669.9 million but a swing to a net loss of US$30.3 million, and updated its fiscal 2025...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-nvst/envista-holdings/news/should-envista-holdings-nvst-mixed-q3-results-and-share-buyb\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0648000940.SGD","symbol_name":"Natixis Harris Associates Global Equity RA SGD","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-nvst/envista-holdings/news/should-envista-holdings-nvst-mixed-q3-results-and-share-buyb","article_id":"2582394828","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-nvst/envista-holdings/news/should-envista-holdings-nvst-mixed-q3-results-and-share-buyb","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2582394828","pubTimestamp":1762885282,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"In late October 2025, Envista Holdings reported third quarter results, showing year-over-year sales growth to US$669.9 million but a swing to a net loss of US$30.3 million, and updated its fiscal 2025 core sales growth forecast to approximately 4%.\nEnvista also completed a significant tranche of its share repurchase program, buying back nearly 8 million shares for US$141.45 million, while year-to-date results reflected improved profitability compared to the prior year.\nWe’ll examine how...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","BK4082":"医疗保健设备","LU0477156797.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"RE\" (USD) ACC","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","NVST":"Envista Holdings","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","LU0130518102.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC"},"translate_title":"Envista Holdings(NVST)好坏参半的第三季度业绩和股票回购是否会促使投资者重新评估？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVST":1.5},"content_text":"In late October 2025, Envista Holdings reported third quarter results, showing year-over-year sales growth to US$669.9 million but a swing to a net loss of US$30.3 million, and updated its fiscal 2025 core sales growth forecast to approximately 4%. Envista also completed a significant tranche of its share repurchase program, buying back nearly 8 million shares for US$141.45 million, while year-to-date results reflected improved profitability compared to the prior year. We’ll examine how Envista’s updated earnings guidance in the face of mixed recent results impacts the company’s overall investment narrative. The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.AdvertisementEnvista Holdings Investment Narrative Recap For investors considering Envista Holdings, the central case remains focused on the company’s ability to drive sustainable growth in digital dentistry and leverage operational improvements to expand margins, particularly as emerging market momentum offsets sluggish developed geographies. The modestly raised core sales growth guidance to approximately 4% is encouraging, but mixed profitability, highlighted by the Q3 net loss, does not materially change the primary near-term catalyst, which is ongoing adoption of digital and AI-enabled dental products. However, margin pressures from Chinese pricing reforms and trade-related costs remain the biggest risk.\n  The completion of the nearly US$141.45 million share repurchase program, totaling nearly 8 million shares bought back in 2025, stands out as the most relevant recent announcement. By reducing the share count, this initiative potentially adds flexibility for future earnings per share growth, though the effectiveness of this move will depend on improving margins and stable revenue expansion from digital product adoption, an area investors are watching closely as a key catalyst.\n  In contrast, investors should also be aware of the lingering threat from intensifying pricing pressures in China, which could...\n Read the full narrative on Envista Holdings (it's free!)Envista Holdings' outlook forecasts $2.8 billion in revenue and $144.7 million in earnings by 2028. This is based on a 3.6% annual revenue growth rate and an earnings increase of $90.9 million from the current $53.8 million.Uncover how Envista Holdings' forecasts yield a $22.00 fair value, a 10% upside to its current price.Exploring Other PerspectivesNVST Earnings & Revenue Growth as at Nov 2025  Three individual fair value estimates from the Simply Wall St Community place Envista shares between US$22 and US$25 each. While community forecasts vary, it is increasingly important to consider how ongoing margin pressures in key international markets could affect both earnings and long-term business stability.\nExplore 3 other fair value estimates on Envista Holdings - why the stock might be worth just $22.00!Build Your Own Envista Holdings NarrativeDisagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.A great starting point for your Envista Holdings research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.Our free Envista Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Envista Holdings' overall financial health at a glance.Ready For A Different Approach?Our top stock finds are flying under the radar-for now. Get in early:Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 24 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.Uncover the next big thing with financially sound penny stocks that balance risk and reward.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Envista Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2582394828","isCrawlerRequest":true}